| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000029603 |
| Receipt No. | R000033823 |
| Scientific Title | Evaluation of effects on cognitive function and swallowing activity following after continuous chewing training with chewing start food of process lead in cerebrovascular disease: an open-label, randomized controlled. |
| Date of disclosure of the study information | 2017/10/20 |
| Last modified on | 2022/10/26 (Ver. 9) |
| Basic information | ||
| Public title | Evaluation of effects on cognitive function and swallowing activity following after continuous chewing training with chewing start food of process lead in cerebrovascular disease: an open-label, randomized controlled. | |
| Acronym | Evaluation of effects on cognitive function and swallowing activity following after continuous chewing training with chewing start food of process lead in cerebrovascular disease. | |
| Scientific Title | Evaluation of effects on cognitive function and swallowing activity following after continuous chewing training with chewing start food of process lead in cerebrovascular disease: an open-label, randomized controlled. | |
| Scientific Title:Acronym | Evaluation of effects on cognitive function and swallowing activity following after continuous chewing training with chewing start food of process lead in cerebrovascular disease. | |
| Region |
|
|
| Condition | |||
| Condition | Cerebral vascular disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We examine to clarify whether improvement on cognitive function and swallowing ability can be seen by performing continuous chewing training for the patients of cerebrovascular disease. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Development of the revised version of Hasegawa's dementia scale.
Mini Mental State Examination. Fujishima dysphagia grade. Dysphagia severity scale. Japanese version the mann assessment of swallowing ability. Jaw opening muscle strength. Intraoral moisture conten. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Educational,Counseling,Training | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Control group.
Regular rehabilitation for 2 months. |
||
| Interventions/Control_2 | Interventions group.
Regular rehabilitation and swallowing chewing twice a day chewing start food process leads for 2 months. |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Hospitalized patients within 2 months had dysphagia showing grade 3 or more in Fujishima grade. They are diagnosed to swallow chewing food of process leads on videofluoroscopic examination in advance. They had cognitive function more than 10 points on development of the revised version of Hasegawa's dementia scale and are able to understand and perform for the order of swallowing that. | |||
| Key exclusion criteria | Person with consciousness disorder, Difficult to instruct chewing and swallowing.
an aphasia. Cerebellar lesion,brain stem lesions including cerebral vascular disease. Eichner's classification A other than A.(Excluding those who have dentures.) |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Medical corporation Sonodakai
Takenotsuka Noushinkei Rehabilitation Hospital |
||||||
| Division name | Department of Rehabilitation | ||||||
| Zip code | 1210064 | ||||||
| Address | 4-15-16, Hokima, Adachi-ku, Tokyo, 121-0064, Japan | ||||||
| TEL | 03-5851-1108 | ||||||
| t_hoshi@reha.sonodakai.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Takenotsuka Noushinkei Rehabilitation Hospital | ||||||
| Division name | Department of Rehabilitation | ||||||
| Zip code | 1210064 | ||||||
| Address | 4-15-16, Hokima, Adachi-ku, Tokyo, 121-0064, Japan | ||||||
| TEL | 03-5851-1108 | ||||||
| Homepage URL | |||||||
| t_hoshi@reha.sonodakai.or.jp | |||||||
| Sponsor | |
| Institute | Medical corporation Sonodakai
Takenotsuka Noushinkei Rehabilitation Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Medical corporation Sonodakai
Takenotsuka Noushinkei Rehabilitation Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical corporation Sonodakai Takenotsuka Noushinkei Rehabilitation Hospital |
| Address | 4-15-16, Hokima, Adachi-ku, Tokyo, 121-0064, Japan |
| Tel | 03-5851-1108 |
| t_hoshi@reha.sonodakai.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033823 |